Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3

Sponsor Class

OTHER 262NETWORK 11NIH 8UNKNOWN 3OTHER_GOV 3INDUSTRY 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 1

Interventions

S 1 (combination) 12Capecitabine 11Paclitaxel 9Cisplatin 9apatinib 8Oxaliplatin 8pyrotinib 6nimotuzumab 6130-nm albumin-bound paclitaxel 6titanium silicide 5sintilimab 5camrelizumab 5anlotinib 5Etoposide 5Docetaxel 5Carboplatin 5Trastuzumab 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4nedaplatin 3Vinorelbine 3Temozolomide 3Tegafur 3Taxes 3Radiosurgery 3Gemcitabine 3Fluorouracil 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Radiosurgery × Clear all
NCT03927898 2019-04-25

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02909114 2016-09-21

Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer

ChineseAMS

Phase 2 Unknown
50 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02584699 2015-10-23

Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC

ChineseAMS

Phase 2 Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡